Back to Research Hub
Haemonetics Corporation
HAE
$79.04+4.16 (+5.56%)
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related…
StreetsValue research for Haemonetics Corporation (HAE)
Members get the full report for Haemonetics Corporation: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.